Borrelia Burgdorferi Bacterin B31 And Ips

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Borrelia Burgdorferi Bacterin B31 And Ips

Administration Routes

Subcutaneous

Species Affected

Dog 12

Most Affected Breeds

Boxer (German Boxer) 3

Crossbred Canine/dog 2

Collie (unspecified) 1

Retriever - Labrador 1

Shih Tzu 1

Pug 1

Terrier - Bull - American Pit 1

Dog (unknown) 1

Corgi (unspecified) 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 4

Anaphylaxis 4

Urticaria 3

Vomiting 3

Anaphylactoid reaction 2

Injection site pain 2

Other abnormal test result NOS 2

Pale mucous membrane 2

Weakness 2

Circulatory collapse (see also 'Neurological' and 'Systemic disorders') 2

Emesis 2

Leucopenia NOS 1

Outcome Breakdown

Ongoing

8 (66.7%)

Recovered/Normal

3 (25.0%)

Outcome Unknown

1 (8.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.